OncoMatch

OncoMatch/Clinical Trials/NCT05419518

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

Is NCT05419518 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies EXTERNAL BEAM RADIATION for neoplasm metastases.

Phase 2RecruitingRutgers, The State University of New JerseyNCT05419518Data as of Jun 2026

Treatment: EXTERNAL BEAM RADIATIONThe investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Additionally, the investigators hypothesize that utilizing a fractionation scheme with an escalated biologically equivalent dose (BED) will result in a higher proportion of participants responding to treatment, and will also lead to more durable responses. Furthermore, the investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 35-45% in painful non-bone metastases

Check if I qualify

Extracted eligibility criteria

Treatments studied

Other

EXTERNAL BEAM RADIATION

Disease stage

Metastatic disease required

Prior therapy

Cannot have received: radiation therapy

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • RWJBarnabas Health - Robert Wood Johnson University Hospital · Hamilton, New Jersey
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus · Lakewood, New Jersey
  • RWJBarnabas Health - Saint Barnabas Medical Center · Livingston, New Jersey
  • Robert Wood Johnson University Hospital · New Brunswick, New Jersey
  • Cancer Institute of New Jersey · New Brunswick, New Jersey

Showing up to 5 US sites.

See all sites on ClinicalTrials.gov →

Frequently asked questions

Is NCT05419518 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior radiation therapy disqualifies patients from enrollment.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify